Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2013-09-22 Capital/Financing Update
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Letter to Ineligible Shareholders 2 pages 114.5KB
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to shareholders regarding a non-renounceable rights issue. It explains the exclusion of certain shareholders from participating directly in the rights issue due to jurisdictional and regulatory reasons and outlines the process for selling shares on their behalf. The document references the rights issue announcement and the offer document lodged with ASX but does not contain financial statements or detailed financial data. It is an announcement related to capital raising activities but is not a full capital/financing update report. Given the content and length (3153 characters), it is best classified as a Capital/Financing Update (CAP) rather than a full report or a regulatory filing or report publication announcement.
2013-09-22 English
Exercise of Options 14 pages 693.8KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX), which is a standard form used to announce the allotment of new shares upon the exercise of options. It details the number of shares issued, exercise price, and compliance with ASX listing rules. The document is a formal announcement of a share issue event, specifically the exercise of options and allotment of shares, rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on capital changes and securities issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief notice but a detailed announcement of a capital change event.
2013-09-17 English
Investor Presentation 30 pages 1.2MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation from Allied Healthcare Group dated September 2013. It includes an overview of the company, its divisions, product pipelines, regulatory approvals, clinical study results, market potential, and future growth prospects. The content is structured as a corporate presentation with slides covering sales, marketing, R&D, product development, and company summary. There is no indication that this is a formal regulatory filing like an annual or interim report, audit report, or earnings release. It is not a transcript of a call or a voting result announcement. The document is clearly a presentation aimed at investors or stakeholders, focusing on financials, strategy, and market position. Therefore, it fits the definition of an Investor Presentation (IP). The document length (13,445 characters) supports that it is a full presentation rather than a brief announcement or notice.
2013-09-10 English
Appendix 3B - Exercise of Options 14 pages 708.7KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX), which is a standard form used to announce the allotment of new securities, specifically the exercise of options and the issuance of ordinary shares. It includes detailed information about the securities issued, exercise prices, shareholder approvals, and compliance with ASX listing rules. The document is not a financial report, earnings release, or management discussion but rather a formal announcement of a capital change event related to share issuance. This fits the definition of a Share Issue/Capital Change announcement (SHA). The document length is substantial and contains detailed data about the issuance, not merely a brief notice or a report publication announcement. Therefore, the correct classification is SHA with high confidence.
2013-09-10 English
Appendix 3B - Exercise of Options 14 pages 694.5KB
Share Issue/Capital Change Classification · 95% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX), which is a standard form used to announce the allotment of new shares upon the exercise of options. It details the number of shares issued, exercise price, and compliance with ASX listing rules. The document is a formal announcement of a share issue event, specifically the exercise of options and allotment of shares, rather than a financial report or earnings release. It does not contain financial statements or management discussion but focuses on capital changes and securities issuance. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed information about the share issue, consistent with a capital change announcement rather than a brief notice or regulatory filing. Confidence is high due to the clear identification of the document as an Appendix 3B new issue announcement and the detailed content about securities issuance.
2013-09-05 English
Appendix 3B - Exercise of Options 14 pages 693.7KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX), which is a standard form used to announce the issue of new securities, specifically the allotment of shares upon exercise of options. It details the number of shares issued, exercise price, and compliance with ASX listing rules. The document is a formal announcement of a capital change event (exercise of options and allotment of shares), not a financial report or earnings release. It does not contain financial statements or management discussion but focuses on the issuance and quotation of new shares. Therefore, it fits the category of Share Issue/Capital Change announcements.
2013-09-03 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.